Saturday, October 5, 2019

Cancer Summit 2019


Trials show, circulating tumor DNA detected through liquid biopsy, to be an independent prognostic marker for identifying patients with colorectal cancer. Explore more oncology, PS: https://cancer-oncology.pulsusconference.com/  

No comments:

Post a Comment